Paper Details

  1. Home
  2. Paper Details

Kushenin Combined with Nucleos(t)ide Analogues for Chronic Hepatitis B: A Systematic Review and Meta-Analysis.

Author: BaiZhaofang, ChenChang, ChenZhe, GongMan, GuoYuming, MaXiao, NiuMing, ShenHonghui, WangJiabo, WangLifu, WeiShizhang, XiaoXiaohe, YangZhirui, ZhangYaming, ZhaoYanling, ZhuYun

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

This meta-analysis examines the efficacy and safety of Kushenin (KS) combined with nucleoside analogues (NAs) for chronic hepatitis B (CHB). KS combined with NAs improved various CHB indices compared to single agents.
Paper Details　
Original Abstract of the Article :
Objective. To evaluate the efficacy and safety of Kushenin (KS) combined with nucleoside analogues (NAs) for chronic hepatitis B (CHB). Methods. Randomized controlled trials (RCTs) of KS combined with NAs for CHB were identified through 7 databases. Frequencies of loss of serum HBeAg, HBeAg seroconv...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4548141/

データ提供：米国国立医学図書館（NLM）

Chronic Hepatitis B: A Desert Oasis of Treatment Options

Chronic hepatitis B (CHB) is a serious liver infection that can lead to cirrhosis and liver cancer. This research explores the efficacy and safety of Kushenin (KS) combined with nucleoside analogues (NAs) for the treatment of CHB. The study found that KS combined with NAs led to improvements in various CHB indices, suggesting that it may be a valuable adjunct to standard care.

Kushenin: A New Oasis in the Desert of CHB Treatment

The study’s findings, like a refreshing oasis in the desert of CHB treatment, offer a potential new approach to managing this condition. The researchers’ observations regarding the benefits of KS in combination with NAs provide valuable insights into the potential for traditional Chinese medicine to complement modern therapies.

Chronic Hepatitis B: A Journey Through a Desert of Challenges

CHB, like a relentless desert wind, can have a significant impact on a person’s health. This research underscores the need for ongoing research to develop effective and safe treatment options for this condition. The study’s findings offer a glimmer of hope, but further research is crucial to fully understand the role of KS in CHB treatment and optimize its use in clinical practice.

Dr.Camel's Conclusion

This study provides evidence for the efficacy and safety of Kushenin (KS) combined with nucleoside analogues (NAs) in the treatment of chronic hepatitis B (CHB). The findings suggest that KS may be a valuable adjunct to standard care, potentially improving treatment outcomes for patients with CHB.

Date :
  1. Date Completed 2015-09-08
  2. Date Revised 2022-03-31
Further Info :

Pubmed ID

26347789

DOI: Digital Object Identifier

PMC4548141

Related Literature

Article Analysis
・Side Effects of adefovir
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.